Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Skin Neoplasms 1Pancreatic Neoplasms 1Melanoma 1

Interventions

Flow Cytometry 4Cyclophosphamide 4Therapeutics 3Polymerase Chain Reaction 3Etoposide 3Carboplatin 3sargramostim 2liposomal amphotericin B 2aldesleukin 2Radiotherapy 2Psychiatric Rehabilitation 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Methylprednisolone 2Itraconazole 2Immunologic Techniques 2Dexamethasone 2Caspofungin 2Calcium Dobesilate 2Busulfan 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2veliparib 1tremelimumab 1trastuzumab deruxtecan 1poly ICLC 1palbociclib 1fludarabine phosphate 1erythromycin propionate-N-acetylcysteinate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × In Situ Hybridization × Dermatologic × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡